Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754910 · ClinicalTrials.gov registry record
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 35
- Enrollment target
NCT00754910 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 35 participants.
The verdict
NCT00754910 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. This may be effective against non-small cell lung cancer. PURPOSE: This clinical trial is studying how well photodynamic therapy using porfimer sodium works in treating patients with non-small cell lung cancer and bronchial disease.
Interventions
- PROCEDURE bronchoscopy
- DRUG porfimer sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754910
The ClinicalTrials.gov registry entry for NCT00754910 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which bronchoscopy is the first listed.
NCT00754910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754910 about?
NCT00754910 is a clinical study titled "Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease". RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. This may be effective against non-small cell lung cancer. PURPOSE: This clinical trial is studying how well photodynamic therapy using por...
What is the current status of trial NCT00754910?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2008-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00754910?
The interventions under investigation include: bronchoscopy (PROCEDURE), porfimer sodium (DRUG).
Who is sponsoring clinical trial NCT00754910?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.